Roles of monoaminergic, glycinergic and GABAergic inhibitory systems in the spinal cord in rats with peripheral mononeuropathy

Brain Research

Volumn 728, Issue 1, 1996, Pages 27-36

  Satoh, Osamu ^a   Omote, Keiichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycine; Hyperalgesia; Monoamine; Neuropathy; Pain; Spinal cord; Aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; BICUCULLINE; DIZOCILPINE; DOPAMINE; GLYCINE; METHYSERGIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; SEROTONIN; STRYCHNINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERALGESIA; INTRATHECAL DRUG ADMINISTRATION; MALE; MONOAMINERGIC SYSTEM; NERVE LIGATION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0030597993     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00371-X     Document Type: Article

References (62)

1. 3 receptormediated antinociception: possible release of GABA, J. Neurosci., 11 (1991) 1881-1888.
2. [2] Bahar, M., Rosen, M. and Vickers, M.D., Chronic cannulation of the intradural or extradural space in the rat, Br. J. Anaesth., 56 (1984) 405-410.
3. [3] Basbaum, A.I., Distribution of glycine receptor immunoreactivity in the spinal cord of the rat: cytochemical evidence for a differential glycinergic control of lamina I and V nociceptive neurons, J. Comp. Neurol., 278 (1988) 330-336.
4. [4] Bennett, G.J. and Xie, Y.-K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, 33 (1988) 87-107.
5. [5] Beyer, C., Roberts, L.A. and Komisaruk, B.R., Hyperalgesia induced by altered glycinergic activity at the spinal cord, Life Sci., 37 (1985) 875-882.
6. [6] Björklund, A. and Skagerberg, G., Evidence for a major spinal cord projection from the diencephalic A11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing, Brain Res., 177 (1979) 170-175.
7. [7] Bowker, R.M., Westlund, K.N. and Coulter, J.D., Origins of serotonergic projections to the spinal cord in rat: an immunocytochemical-retrograde transport study. Brain Res., 226 (1981) 187-199.
8. [8] Budai, D., Wilcox, G.L. and Larson, A.A., Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo, Neurosci. Lett., 135 (1992) 265-268.
9. [9] Carlton, S.M., Doughty, P.M., Pover, C.M. and Coggeshall, R.E., Neuroma formation and numbers of axons in a rat model of experimental peripheral neuropathy, Neurosci. Lett., 131 (1991) 88-91.
10. [10] Castro-Lopes, J.M., Tavares, I., Tölle, T.R., Coito, A. and Coimbra, A., Increase in GABAergic Cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb in the rat, Eur. J. Neurosci., 5 (1992) 296-301.
11. [11] Castro-Lopes, J.M., Tavares, I. and Coimbra, A., GABA decreases in the spinal cord dorsal horn after peripheral neurectomy, Brain Res., 620 (1993) 287-291.
12. B receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy, Brain Res., 679 (1995) 289-297.
13. [13] Colado, M.I., Rio, J.D. and Peralta, E., Neonatal guanethidine sympathectomy suppresses autotomy and prevents changes in spinal and supraspinal monoamine levels induced by peripheral deafferentation in rats, Pain, 56 (1994) 3-8.
14. [14] Davar, G., Hama, A., Deykin, A., Vos, B. and Maciewicz, R., MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy, Brain Res., 553 (1991) 327-330.
15. [15] Dubner, R. and Ruda, M.A., Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci., 15 (1992) 96-103.
16. [16] Feria, M., Abreu, P., Abad, F. and Sánchez, A., Relationship between autotomy behaviour and spinal monoaminergic levels in rats, Pain, 48 (1992a) 429-437.
17. [17] Feria, M., Sánchez, A., Abad, F. and Abreu, P., Effects of selective neurotoxic lesion of lumbosacral serotonergic and noradrenergic systems on autotomy behaviour in rats, Pain, 51 (1992b) 101-109.
18. [18] Game, C.J.A. and Lodge, D., The pharmacology of the inhibition of dorsal horn neurons by impulses in myelinated cutaneous afferents in the cat, Exp. Brain Res., 23 (1975) 75-84.
19. [19] Gobel, S., Golgi studies of the neurons in layer II of the dorsal horn of the medulla (trigeminal nucleus caudalis), J. Comp. Neurol., 180 (1978) 395-414.
20. [20] Godefroy, F., Weil-Fugazza, J. and Besson, J,-M., Complex temporal changes in 5-hydroxytryptamine synthesis in the central nervous system induced by experimental polyarthritis in the rat, Pain, 28 (1987) 223-238.
21. [21] Hökfelt, T., Phillipson, O. and Goldstein, M., Evidence for a dopaminergic pathway in the rat descending from the A11 cell group to the spinal cord, Acta Physiol. Scand., 107 (1979) 393-395.
22. [22] Holstege, J.C., Ultrastructural evidence for GABAergic brain stem projections to spinal motoneurons in the rat, J. Neurosci., 11 (1991) 159-167.
23. [23] Holstege, J.C. and Bongers, C.M.H., A glycinergic projection from the ventromedial lower brainstem to spinal motoneurons. An ultrastructural double labeling study in rat, Brain Res., 566 (1991) 308-315.
24. [24] Jensen, T.S. and Smith, D.F., Dopaminergic effects on tail-flick response in spinal rats, Eur. J. Pharmacol., 79 (1982) 129-133.
25. [25] Jensen, T.S. and Yaksh, T.L., Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats, Brain Res., 296 (1984) 285-293.
26. [26] Johnson, J.W. and Ascher, P., Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325 (1987) 529-531.
27. [27] Kelly, J.S., Zehava, G. and Schon, F., Reduction in GAD I activity from the dorsal lateral region of deafferented rat spinal cord, Brain Res., 26 (1973) 73-87.
28. [28] Lindroth, P. and Mopper, K., High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde, Anal. Chem., 51 (1979) 1667-1674.
29. [29] Magnusson, T., Effect of chronic transection on dopamine, noradrenaline and 5-Hydroxytryptamine in the rat spinal cord, NaunynSchmiedeberg's Arch. Pharmacol., 278 (1973) 13-22.
30. [30] Magoul, R., Onteniente, B., Geffard, M. and Calas, A., Anatomical distribution and ultrastructural organization of the GABAergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies, Neuroscience, 20 (1987) 1001-1009.
31. [31] Mao, J., Price, D.D., Hayes, R.L., Lu, J, and Mayer, D.J., Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy, Brain Res., 598 (1992) 271-278.
32. [32] Mao, J., Price, D.D., Mayer, D.J., Lu, J. and Hayes, R.L., Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy, Brain Res., 576 (1992) 254-262.
33. [33] Munger, B.L., Bennett, G.J. and Kajander, K.C., An experimental painful peripheral neuropathy due to nerve constriction 1. axonal pathology in the sciatic nerve, Exp. Neurol., 118 (1992) 204-214.
34. [34] Murase, K., Ryu, P.D. and Randic, M., Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons, Neurosci. Lett., 103 (1989) 56-63.
35. [35] Nygren, L.-G. and Olson, L., A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord, Brain Res., 132 (1977) 85-93.
36. [36] Powell, J.J. and Todd, A., Light and electron microscope study of GABA-immunoreactive neurones in lamina III of rat spinal cord, J. Comp. Neurol., 315 (1992) 125-136.
37. [37] Reichling, D.B. and Basbaum, A.I., Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: I. GABA-immunoreactive projection neurons in the periaqueductal gray and nucleus raphe magnus, J. Comp. Neurol., 302 (1990) 370-377.
38. [38] Rudomin, P., Presynaptic inhibition of muscle spindle and tendon organ afferents in the mammalian spinal cord, Trends Neurol. Sci., 13 (1990) 499-505.
39. [39] Schmauss, C., Hammond, D.L., Ochi, J.W. and Yaksh, T.L., Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord, Eur. J. Pharmacol., 90 (1983) 349-357.
40. A and glycine receptors to central sensitization: Disinhibition and touchevoked allodynia in the spinal cord, J. Neurophysiol., 72 (1994) 169-179.
41. [41] Sivilotti, L. and Nistri, A., GABA receptor mechanisms in the central nervus system, Prog. Neurobiol., 36 (1991) 35-92.
42. [42] Sluka, K.A. and Westlund, K.M., Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NKl receptor antagonists, Brain Res., 627 (1993) 89-103.
43. [43] Sluka, K.A., Jordan, H.H., Willis, W.D. and Westlund, K.N., Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on spinal release of amino acids after development of acute arthritis in rats, Brain Res., 664 (1994) 77-84.
44. B receptor antagonist in rats, J. Pharmacol. Exp. Ther., 271 (1994) 76-82.
45. [45] Smith, G.D., Wiseman, J., Harrison, S.M., Elliott, P.J. and Birch, P.J., Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation, Neurosci. Lett., 165 (1994) 79-83.
46. [46] Sorkin, L.S., Westlund, K.N., Sluka, K.A., Dougherty, P.M. and Willis, W.D., Neural changes in acute arthritis in monkeys. IV. Time-course of amino acid release into the lumbar dorsal horn, Brain Res. Rev., 17 (1992) 39-50.
47. [47] Sosnowski, M. and Yaksh, T.L., Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism, Anesth. Analg., 69 (1989) 587-592.
48. [48] Stevens, R.T., Hodge Jr., C.J. and Apkarian, A.V., Kölliker-Fuse nucleus: the principal source of pontine catecholaminergic cells projecting to the lumbar spinal cord of cat, Brain Res., 239 (1982) 589-594.
49. [49] Sugimoto, T., Bennett, G.J. and Kajander, K.C., Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine, Pain, 42 (1990) 205-213.
50. [50] Todd, A.J. and McKenzie, J., GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord, Neuroscience, 31 (1989) 799-806.
51. [51] Todd, A.J. and Sullivan, A.C., Light microscope study of the coexistence of GABA-like and glycine-like immunoreactivities in the spinal cord of the rat, J. Comp. Neurol., 296 (1990) 496-505.
52. [52] Ungerstedt, U., Stereotaxic mapping of the monoamine pathways in the rat brain, Acta Physiol. Scand., 367 (1971) 1-49.
53. [53] Weil-Fugazza, J., Godefroy, F., Manceau, V. and Besson, J.M., Increased norepinephrine and uric acid levels in the spinal cord of arthritic rats, Brain Res., 374 (1986) 190-194.
54. [54] Westlund, K.N., Bowker, R.M., Ziegler, M.G. and Coulter, J.D., Noradrenergic projections to the spinal cord of the rat, Brain Res., 263 (1983) 15-31.
55. [55] Willcockson, W.S., Chung, J.M., Hori, Y., Lee, K.H. and Willis, W.D., Effects of iontophoretically released amino acids and amines on primate spinothalamic tract cells, J. Neurosci., 4 (1984) 732-740.
56. [56] Woolf, C.J. and Thompson, S.W.N., The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain, 44 (1991) 293-299.
57. [57] Yaksh, T.L., Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists, Pain, 37 (1989) 111-123.
58. [58] Yaksh, T.L., Yamamoto, T, and Myers, R.R., Pharmacology of nerve compression-evoked hyperesthesia. In W.D. Willis Jr. (Ed.), Hyperalgesia and Allodynia, Raven Press, New York, 1992, pp. 245-258.
59. [59] Yamamoto, T., Shimoyama, N. and Mizuguchi, T., Role of the injury discharge in the development of thermal hyperesthesia after sciatic nerve constriction injury in the rat, Anesthesiology, 79 (1993) 993-1002.
60. [60] Yamamoto, T. and Yaksh, T.L., Effects of intrathecal strychnine and bicuculline on nerve compression-induced thermal hyperalgesia and selective antagonism by MK-801, Pain, 54 (1993) 79-84.
61. [61] Yamamoto, T., Shimoyama, N., Asano, H. and Muzuguchi, T., Time-dependent effect of morphine and time independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat, Anesthesiology, 80 (1994) 1311-1319.
62. [62] Zarbin, M.A., Wamsley, J.K. and Kuhar, M.J., Glycine receptor: light microscopic autoradiographic localization with [3H]strychnine, J. Neurosci., 1 (1981), 532-547.